This Week’s CGT News: CRISPR Hits Phase 3 Milestone
May 4, 2026
Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal
6 min read
False
Advertisement
Research News
This Week’s CGT News: New FDA Genome Editing Guidance
April 20, 2026
Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T
4 min read
Cell and Gene Roundup: CAR T Breaks New Ground
April 15, 2026
A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
5 min read
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease
April 13, 2026
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
2 min read
New Iron-Tracking Tool Could Boost Cartilage Regeneration Therapies
April 10, 2026
MIT-led team develops rapid, non-destructive method to predict stem cell quality during manufacturing
1 min read
Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda
April 9, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
1 min read
Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
April 8, 2026
Circular single-stranded donors help recombinases bypass immune defenses, unlocking in vivo gene insertion
2 min read
Alzheimer’s Drug Lecanemab Works by “Switching On” the Brain’s Cleanup Cells
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
Review: Making Better Antibodies at Scale
April 6, 2026
A new review unpacks how GMP standards, evolving regulations, and emerging production technologies are reshaping monoclonal antibody manufacturing
3 min read
How AI is Reshaping Biologic Drug Discovery
April 6, 2026
Review charts rise of language models, AlphaFold, and generative AI in engineering next-generation therapeutics
2 min read
